i-Tracker anti-Adalimumab
Product Description
i-Tracker anti-Adalimumab is an automated assay intended for the quantitative measurement of anti-Adalimumab antibodies (anti-drug antibodies: ADAb) in human serum or plasma samples
- Innovative CLIA technology
- Quantitative measurement of drug and anti-drug antibodies
- First results in less than 35 minutes; 60 results/hour
- Validated on Adalimumab drug (Humira®) and biosimilars: ABP 501 (Amgevita®) and SB5 (Imraldi®)
-
- Bressler B & al. Clinical Practice Guidelines for the Medical Management of Non-hospitalized Ulcerative Colitis: The Toronto Consensus. Gastroenterology 2015;148:1035 – 1058.
- Diagnostics Guidance [DG22] on Therapeutic monitoring of TNF-alpha Inhibitors in Crohn’s Disease. https://www.nice.org.uk/guidance/dg22/chapter/1-Recommendations
- Maaser C et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019 Feb 1;13(2):144-164.
- Gomollón F at al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease. J Crohns Colitis. 2016:1-23.
- Ruemmele F.M. et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. Journal of Crohn’s and Colitis (2014).
- Wadhwa M et al. World Health Organization, WHO Expert Committee on Biological Standardization. (2019). Report on a collaborative study for proposed 1st international standard for Adalimumab. WHO/BS/2019.2365.
- Product Code: CTA 003-100
- Number of Tests: 100
- Sample Type: Serum or plasma
- Sample Volume: 100 µL
- Assay Range: 10 - 2000 ng/mL
- Add to Enquiry Basket
Interested? Enquire now.
Add to Enquiry Basket
Related Products
| Assays | Certification | Platform | Clinical Area | Portfolio | RUO/IVD |
|---|---|---|---|---|---|
| i-Tracker Adalimumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker anti-Infliximab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker anti-Certolizumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker anti-Golimumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker anti-Rituximab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker anti-Ustekinumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker anti-Vedolizumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |